COMPARISON OF INTRAVENOUS (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE AND VOLUME REPLETION IN TUMOUR-INDUCED HYPERCALCAEMIA
- 1 July 1983
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 322 (8344), 239-243
- https://doi.org/10.1016/s0140-6736(83)90231-3
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- RENAL FAILURE ASSOCIATED WITH INTRAVENOUS DIPHOSPHONATESThe Lancet, 1983
- Efficacy of amino-hydroxypropylidene bisphosphonate in hypercalcemia: Observations on regulation of serum calciumCalcified Tissue International, 1982
- Comparison of two parenteral diphosphonates in hypercalcemia of malignancyAmerican Journal Of Medicine, 1982
- Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases.JCI Insight, 1980
- INHIBITION OF OSTEOLYTIC BONE LESIONS BY (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (A.P.D.)The Lancet, 1979
- Effect of mithramycin therapy on strontium and calcium metabolism in cancer patients (A preliminary report)Journal of Surgical Oncology, 1972
- New approach to the treatment of hypercalcemia The effect of short‐term treatment with mithramycinClinical Pharmacology & Therapeutics, 1971
- Mithramycin treatment of hypercalcemiaCancer, 1970
- Precipitous Fall in Serum Calcium, Hypotension, and Acute Renal Failure After Intravenous Phosphate Therapy for HypercalcemiaAnnals of Internal Medicine, 1967
- A specific method for the analysis of hydroxyproline in tissues and urineAnalytical Biochemistry, 1960